Morepen Laboratories plans to launch loratidine in the US market in December this year. The company hopes to achieve a turnover of at least Rs 200 crore from the anti-histaminic drug in the first year itself.
Morepen Laboratories plans to launch loratidine in the US market in December this year. The company hopes to achieve a turnover of at least Rs 200 crore from the anti-histaminic drug in the first year itself.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 08 2002 | 12:00 AM IST